NCT Number: NCT01798199
Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment Project
Virtual environments and information communication technologies (ICT) offer large perspectives in the field of assistive care and rehabilitation.
As potentially endless, the scenarios and environment used using 3D can provide immersive social and interactive context for enjoyable and therapeutic exercises in the aging population. In addition it is also possible to use this type of serious game and scenario in very easy to use devices such as lap top or tablet.
Social exclusion has many causes, Apathy as one of the most common behavioural disturbances found in old adults populations alters significantly social and emotional interaction.
Even though, progress in VR has been made over the past year, the presence of such technology in daily living space is still at the embryonic stage.
The European e-Inclusion policy stresses the importance of ICT in improving the quality of life in potentially disadvantaged groups, including older people and persons.
The VERVE project is developing ICT tools to support the treatment of people who are at risk of social exclusion due to apathy associated with a disability.
As people aged and autonomy worsen fear for safety and comfortable means to maintain social and Health Related Quality of Life (HRQL) status are public health issues.
Moreover, even though older adults would like to perform some activities such as walking in the streets some are reluctant to go out of their homes as the external environment is perceived as potentially unsafe.
Apathy, the most common behavioural symptoms in aging population is characterized by symptoms of reduced initiation and responsiveness to environmental interactions. The syndrome of Apathy takes form of diminished goal-directed behaviour, characterised by emotional blunting, loss of initiative and loss of interest. Apathy along with the nosological characteristics of dementia induces impairment in autonomy level and therefore dependence as cognitive impairments worsened.
The importance of stimulation could be related to the concept of engagement defined as the act of being occupied or involved with an external stimulus. Engaging older person with or without Alzheimer's disease and related disorders in appropriate activities has been shown to yield beneficial HRQL effects such increasing positive emotion, improving cognition, functional autonomy and quality of life.
Accordingly, enriched environments with high definition virtual representation of cities and activities of interest have the potentials not only to encourage patients to get active in a safe and interactive environment but also to create access to enjoyable and stimulating settings for the more severe patients.
The VR setting from VERVE proposed personalised and populated environments available on two different, but interlinked hardware platforms: 1/: standard gaming set-up in the home, nursing home or day hospital therapy group; and 2/ mobile tracked internet devices (e.g.,IPad). The system will ensure maximum openness and dissemination by using 3D Web technologies.
Looking for future studies?
Notify MeKey information
Conditions
Age range
60 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
CHU de Nice, Nice, France
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
to MILD COGNITIVE IMPAIRMENT:
- Male or Female aged ≥ 60 years.
- Subject presenting a diagnosis of MCI according to the criteria of the National Institute on Aging and Alzheimer Association group (Albert M.S., 2011) ; or Alzheimer disease at the prodromal stage (Dubois B., 2010 )
- Subject presenting a score of 0 at the " Tremor " and " Rigidity " items from the UPDRS III
- Patient not presenting a major depression episode according to the DSM IV-R;
- Be affiliate to the social security system (For French patients only);
- Case of patients under guardianship after agreement of the guardian (legal entity);
- Signed and dated a written informed consent obtained from the subject
Exclusion criteria
to MILD COGNITIVE IMPAIRMENT:
-
Treatment and study plan
Primary outcomes
-
the participants and careers acceptability
Time frame: 8 weeks
The primary objective is to evaluate the participants and careers acceptability in short and long term use of the VERVE light portable system used for cognitive stimulation of patients with cognitive pathologies.
Secondary outcomes
-
To assess the impact of behavioral disturbances over the use of the VR using the NPI and the Apathy Inventory
Time frame: at 3, 4 and 8 weeks
To assess the impact of behavioral disturbances over the use of the VR using the NPI and the Apathy Inventory
-
To describe the parameters those facilitate engagement within the designs of VERVE VR setting using the engagement scale OME
Time frame: at 1, 2, 3, a weeks
To describe the parameters those facilitate engagement within the designs of VERVE VR setting using the engagement scale OME
-
To assess the potential acceptability and preventive effectiveness of such setting in home setting using visual analogic scale and EQ-D6
Time frame: at 3, 4, 8 weeks
To assess the potential acceptability and preventive effectiveness of such setting in home setting using visual analogic scale and EQ-D6
-
To assess cognitive impact of the light VERVE setting. Using Stroop, TMT, VAT and functional task (IADL)
Time frame: First day and 4 weeks
To assess cognitive impact of the light VERVE setting. Using Stroop, TMT, VAT and functional task (IADL)
Sponsors and collaborators
Lead sponsor
Centre Hospitalier Universitaire de Nice
Other
Registry information
Official study title
VERVE* PROJECT: Study of the Acceptability of a Virtual Reality System on the Cognitive Stimulation of Patients With Alzheimer's Disease or Related Conditions. (*Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment)
Acronym: VERVE
Important dates
- Study start
- 2013
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Feb 25, 2013
- Registry last updated
- Sep 1, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia
NCT05519137
Alzheimer Disease, Alzheimer's Disease
Menands, New York, United States
View Trial DetailsA Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)
NCT04867616
Alzheimer Disease, Alzheimer's Disease
Fresno, California, United States
View Trial DetailsImpact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease
NCT02947893
Alzheimer Disease, Alzheimer's Disease
Washington D.C., District of Columbia, United States
View Trial DetailsLeucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease
NCT06206824
Abnormalities, Multiple, Alzheimer Disease
Gières, France
View Trial Details